Granted Patent
B2
US 7,714,123 · App. 11/924,204 · Granted May 11, 2010
Crystalline forms of an antiviral benzimidazole compound
Assignee:
GlaxoSmithKline LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1Hbenzimidazole, pharmaceutical compositions comprising the same, processes for preparing the same, and their use in medical therapy.
Claims (1)
1. A process for the production of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole in an anhydrous crystalline form, the process comprising treating 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole with a solubilizing solvent serving to convert an amount of 5,6-dichloro-2-(isopropylamino)1-β-L-ribofuranosyl-1H-benzimidazole into one or more of the anhydrous crystalline forms and/or solvates.
Assignments (1)
CHANGE OF NAME
Recorded Jan 19, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 023805/0094 →
Priority Claims (1)
GB 9807354.7
· Apr 7, 1998
· national
Continuity (3)
Continuation
0964796200